Hazlett, Burt & Watson’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110K Sell
929
-271
-23% -$31.3K 0.03% 351
2026
Q1
$142K Buy
1,200
+8
+0.7% +$1.05K 0.04% 294
2025
Q4
$162K Buy
1,192
+442
+59% +$63.6K 0.05% 283
2025
Q3
$110K Buy
750
+116
+18% +$16.1K 0.04% 304
2025
Q2
$82K Buy
634
+27
+4% +$3.27K 0.03% 308
2025
Q1
$71K Sell
607
-50
-8% -$6.2K 0.03% 316
2024
Q4
$76K Buy
657
+1
+0.2% +$126 0.03% 307
2024
Q3
$88K Buy
656
+315
+92% +$42.1K 0.04% 292
2024
Q2
$46K Buy
341
+2
+0.6% +$272 0.02% 348
2024
Q1
$43K Buy
339
+220
+185% +$26.6K 0.03% 347
2023
Q4
$13K Buy
119
+100
+526% +$9.98K 0.01% 470
2023
Q3
$2K Buy
+19
New +$1.96K ﹤0.01% 660

Other funds holding XYL

Hazlett, Burt & Watson's XYL Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its Xylem (XYL) stake by 23% in Q2 2026, selling an estimated $31.3K and leaving 929 shares worth $110K. The position accounts for 0.03% of the portfolio, ranked #351.

Hazlett, Burt & Watson first reported a position in XYL in Q3 2023 and has held it in 12 quarters since. The position peaked at $162K in Q4 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Hazlett, Burt & Watson held 929 shares of Xylem worth $110K as of Q2 2026.
  • Hazlett, Burt & Watson sold 271 Xylem shares in Q2 2026, an estimated $31.3K.
  • Xylem made up 0.03% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #351 holding.
  • Hazlett, Burt & Watson first reported a position in Xylem in Q3 2023 and has held it in 12 quarters since.
  • Hazlett, Burt & Watson's Xylem position peaked at $162K in Q4 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.